Patient: Page 4
-
iStock via Getty Images
Democrats think they've found a balance between drug innovation and pricing negotiation
A look at Congress’ push to pass drug pricing reform and why the latest attempt could actually succeed.
By Karissa Waddick • July 26, 2022 -
Stock via Getty Images
The earlier the better: New consortium leverages infant screening to accelerate treatment
Inozyme Pharma has joined a genomic sequencing program developing a novel rapid test for 388 genetic diseases.
By Kim Ribbink • July 25, 2022 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCell and gene therapies
How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.
By PharmaVoice staff -
Chris Hondros / Staff via Getty Images
Q&ABehind Pfizer's new quest to target a 'transformation' in pharma
A combined venture with Roivant — called Priovant Therapeutics — is looking to be a forerunner in the burgeoning autoimmune disease market.
By Kelly Bilodeau • July 25, 2022 -
Maddie Meyer / Staff via Getty Images
Moderna's next vax target? A little-known cause of birth defects
How the mRNA-based biotech is developing the first-ever prophylactic for a devastating virus.
By Karissa Waddick • July 21, 2022 -
Permission granted by John LaMattina
Pfizer's former R&D head takes on drug pricing misconceptions in new book
John LaMattina has something to say about the industry — and he hopes patients are listening.
By Meagan Parrish • July 19, 2022 -
NanoStockk/istockphoto.com
Sponsored by OPEN HealthHow digital health is changing the relationship between patients and health providers
The pandemic has forced the pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes
July 18, 2022 -
FG Trade via Getty Images
ProfileThe power of the underdog: A rare disease nonprofit working to help patients win against the odds
Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.
By Alexandra Pecci • July 13, 2022 -
iStock via Getty Images
Pharma companies take a fresh approach to inclusion in new DTC ads
AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.
By Karissa Waddick • July 5, 2022 -
iStock via Getty Images
With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points
The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.
By Karissa Waddick • June 28, 2022 -
Stock via Getty Images
The oncology market is surging despite a decline in routine screenings
A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.
By Kelly Bilodeau • June 28, 2022 -
Permission granted by Dan Vahdat.
Q&A'Nobel Prize of pharma' helps put Huma's digital health platform on the global map
The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.
By Kim Ribbink • June 23, 2022 -
Karissa Waddick/PharmaVoice
#DIA2022: Building 'guardrails' in the FDA's accelerated approval program
Regulatory experts weigh in on ways to enhance the controversial drug approval approach.
By Karissa Waddick • June 21, 2022 -
Valiantsin Suprunovich via Getty Images
The public health sleuth
In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.
By Alexandra Pecci • June 21, 2022 -
Stock via Getty Images
Q&A // Biotech SpotlightBiotech spotlight: Karuna Therapeutics’ mission to rejuvenate the field of neuroscience
An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.
By Kim Ribbink • June 16, 2022 -
ChiccoDodiFC via Getty Images
A patient-funded ALS drug offers hope where few treatments exist
Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.
By Kelly Bilodeau • June 15, 2022 -
Stock via Getty Images
Q&AA combo of precision meds and diagnostics could disrupt mental healthcare
HMNC Brain Health, a clinical-stage company, is leveraging cutting-edge tech to offer a new approach to mental health challenges.
By Kelly Bilodeau • June 8, 2022 -
Stock via Getty Images
ProfileAfter losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development
The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.
By Alexandra Pecci • June 7, 2022 -
Jonathan Ross via Getty Images
Pharma giants take on Appalachian cancer rates in newest screening initiative
AstraZeneca and Bristol Myers Squibb are teaming up with the nonprofit Association of Community Cancer Centers to increase lung cancer screening in rural Appalachia for the long haul.
By Karissa Waddick • June 7, 2022 -
iStock via Getty Images
Aduhelm's Medicare woes leave questions about lofty premiums
A single drug’s effect on the premiums that Medicare beneficiaries pay is raising questions about how these levels are set and what factors play a part.
By Kelly Bilodeau • June 2, 2022 -
AndreyPopov via Getty Images
Pharmas can be 'more than medicine' by focusing on preventative care
Why pharma companies are changing their tack to become more than the products they sell.
By Michael Gibney • May 24, 2022 -
Stock via Getty Images
Q&AThe UK-based company that's striving to overcome the limitations of T cell receptor innovation
Etcembly’s CEO, Michelle Teng, shares why a platform approach to T cell receptors can advance and democratize innovation.
By Kim Ribbink • May 23, 2022 -
sturti via Getty Images
Sponsored by ClinicalMind3 things medical communications can learn from sales training experts
Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to "stick".
May 23, 2022 -
John Moore via Getty Images
A potential COVID-19 EUA could turn this small biotech into a household name
Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.
By Meagan Parrish • May 19, 2022 -
Permission granted by SpringWorks/Jim Cassidy
ProfileJumping into pharma with big plans at a small company
SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.
By Alexandra Pecci • May 17, 2022 -
Spencer Platt via Getty Images
Q&ABriOri BioTech sets the stage for the comeback of Vioxx
With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.
By Kelly Bilodeau • May 17, 2022
Previous
